Stock
Recursion Pharmaceuticals In
Ticker not mapped · held by 14 managers
Reported value
$51M
Holders
14
+1 new · −0 exited
Holders’ est. mark
−$228.1K
Price effect on 4 books still in the name
Largest holder
$35.6M
MORGAN STANLEY
Holder count by quarter
Who holds it
Notable only| Investor | Shares | Value | Est. mark | Change |
|---|---|---|---|---|
| MORGAN STANLEY | 7.29M | $35.6M | — | Held |
| BARCLAYS PLC | 1.55M | $7.57M | −$209.6K | Added$1.67M |
| BANK OF AMERICA CORP /DE/ | 1.22M | $5.97M | — | Held |
| Hudson Bay Capital Management LP | 225K | $1.1M | — | Held |
| Leonteq Securities AG | 67K | $327K | −$11.7K | Cut−$1.94K |
| Cresset Asset Management, LLC | 39.3K | $191.7K | −$4.35K | Added$69.5K |
| Swiss Life Asset Management Ltd | 13.4K | $65.4K | — | New |
| Sanctuary Advisors, LLC | 13.2K | $64.2K | −$2.37K | Cut−$12.5K |
| IFP Advisors, Inc | 10.4K | $50.5K | — | Held |
| Allworth Financial LP | 9.55K | $46.6K | — | Held |
| Scarborough Advisors, LLC | 1.51K | $7.37K | — | Held |
| Cape Investment Advisory, Inc. | 350 | $1.71K | — | Held |
| KBC Group NV | 12.3K | $60 | — | Held |
| FNY Investment Advisers, LLC | 4.12K | $20 | — | Held |
Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.